3 Healthcare Stocks with ‘Strong Buy’ Analyst Ratings and ‘Perfect 10’ Smart Scores
Eli Lilly ($LLY), UnitedHealth ($UNH), and Gilead Sciences ($GILD) are three healthcare stocks with Strong Buy analyst ratings. All three stocks al...
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Locust Wood Capital Advisers Stephen J. Errico | 33,522 | $38,787,670 | -16% | 0.88% |
| 2. | Bourgeon Capital John Zaro | 24,270 | $28,081,987 | -1% | 4.03% |
| 3. | Lee Munder Capital Group Lee Munder | 20,080 | $23,234,166 | -2% | 1.25% |
| 4. | Bailard Inc Thomas Bailard | 13,770 | $15,933,215 | +2% | 0.32% |
| 5. | Ayrshire Capital Management John Nevin Jr. | 6,440 | $7,451,491 | -3% | 3.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,402.52 | 5,000 | $7,012,600.00 | 4,137 | 2026-11-02 | Filing | |
| $1,175.10 | 6,500 | $7,638,150.00 | 54,147 | 2026-08-17 | Filing | |
| $1,185.01 | 2,000 | $2,370,020.00 | 1,526 | 2026-08-10 | Filing | |
| $1,190.00 | 5,000 | $5,950,000.00 | 11,875 | 2026-08-07 | Filing | |
| $1,150.77 | 2,500 | $2,876,925.00 | 29,804 | 2026-06-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 90,066,978 | $104,214,698,904 | 100% | |
| 2. | 1,839,623 | $2,128,590,981 | 1.22% | |
| 3. | 1,742,837 | $2,016,601,839 | 1.71% | |
| 4. | 1,478,787 | $1,711,074,659 | 23.01% | |
| 5. | 1,321,534 | $1,529,121,769 | 0.78% |
News See All
Eli Lilly Stock (LLY) Soars as Financial Results Crush Wall Street Estimates
The pharma giant raised its sales guidance.
Options Volatility and Implied Earnings Moves Today, October 29, 2026
Today, several major companies are expected to report earnings: Altria Group (MO), Amazon (AMZN), Eli Lilly & Co (LLY), Intel (INTC), Mastercard (M...
Novo Stock (NVO) Falls After Another Head-to-Head Obesity Trial Loss to Eli Lilly
Shares of Danish pharma giant Novo ($NVO) edged lower to around $38 on Wednesday afternoon. This came after rival drugmaker Eli Lilly ($LLY) announ...
Eli Lilly’s (LLY) Head of International Business Retires
The pharma giant reports financial results on Oct. 29.
Jim Cramer is Bullish on These 10 Stocks
Investors are closely watching the artificial intelligence trade amid mounting concerns over massive spending on AI infrastructure, the sustainability of growth and whether companies can generate sufficient...
Wall Street Has High Expectations for Eli Lilly Stock (LLY) Heading into Earnings
The company report earnings on Oct. 29.
Options Volatility and Implied Earnings Moves This Week, October 26 – October 30, 2026
This week, several major companies will be reporting earnings. Among them are Amazon (AMZN), Microsoft (MSFT), Alphabet Class A (GOOGL), Alphabet C...
The Week That Was, The Week Ahead: Macro and Markets, October 25
U.S. stocks finished Friday lower as rising oil prices and renewed inflation concerns weighed on Wall Street. The Dow Jones Industrial Average (DJI...
Polen Focus Growth Strategy Trims Eli Lilly and Company (LLY) While Maintaining Confidence in Its Outlook
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center